BRCA Gene Rearrangement clinical trials at UCSF
1 research study open to eligible people
BRCA gene rearrangement refers to changes in the BRCA gene linked to cancer. UCSF is testing how computer technology can help match cancer patients with clinical trials. They are also studying the usefulness and practicality of using artificial intelligence in cancer treatment.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
open to all eligible people
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
San Francisco, California and other locations
Last updated: